Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 15, 2015

Primary Completion Date

May 1, 2024

Study Completion Date

June 27, 2024

Conditions
Full Thickness Rotator Cuff Tear
Interventions
BIOLOGICAL

Mesenchymal stem cell augmentation in rotator cuff repair

Patients undergoing mesenchymal stem cell augmentation will receive a total injection of 6 milliliters (mL). Of this, 3 mL will be injected in the tendon at the junction between bone and tendon, while 3 mL will be injected in the bone at the site of the surgical footprint.

PROCEDURE

Standard arthroscopic rotator cuff repair

All patients will undergo full thickness rotator cuff repair using a double row, transosseous-equivalent (TOE) repair with anchor/suture technique. Acromioplasty will be performed in all patients. Alternate procedures such as biceps tenotomy/tenodesis and distal clavicle excision will be performed at the discretion of the surgeon and recorded.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT02484950 - Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair | Biotech Hunter | Biotech Hunter